CD8A and neoplasm: Recent single-cell analysis technology has revealed that PD-1 blockade therapy results in replacement of CD8+ T cell clones at tumor sites through depletion of terminally exhausted T cells and expansion of progenitor exhausted T cells in responsive patients (34, 35).